Bile acid pill may shrink gallbladder polyps, study hopes
NCT ID NCT06278090
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether ursodeoxycholic acid, a bile acid pill, can reduce the size of gallbladder polyps in 36 patients. The goal is to see if the treatment can help patients avoid surgery or frequent follow-up scans. Participants take the pill daily for at least six months, and their polyp size is tracked over a year.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ursodeoxycholic acid
- What this could lead to
- If it works, this could offer a non-surgical way to manage gallbladder polyps and reduce unnecessary follow-ups.
- What could go wrong
- This is a small observational study, not a randomized trial, so results may be less reliable. The treatment may not shrink polyps for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 36 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2024
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Consecutive patients referred for an outpatient consultation to the Departments of Surgery and Gastroenterology due to gallbladder polyps.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with gallbladder polyps eligible for standard follow up (without indication for cholecystectomy or patient decline surgery or polyps \< 5mm without risk factors such as age\>60 years, primary sclerosing cholangitis, asian ethnicity, sessile polypoid lesion) Exclusion Criteria: * Patients with gallbladder polyps that received ursodeoxycolic acid doses lower than 10mg/kg/day
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gallbladder polyp are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario General de Villalba
Collado Villalba, Madrid, 28400, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.